Pivotal trial to evaluate the safety and clinical efficacy of the VDyne System for the treatment of symptomatic severe or greater tricuspid regurgitation.

Tricuspid Valve RegurgitationTricuspid Valve DiseaseCardiovascular Diseases (CVD)+5 more

~Estimated

~$10 – $8,750

VDyne, Inc.NCT07516444

Observational

Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial

To learn if the Creating Opportunities for Personal Empowerment (COPE) intervention is feasible, acceptable, and helpful (compared to usual care) in women with…

COPEBreast CancerFirst Line Therapy+1 more

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07610499